Clinical trial
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With…
NCT00210028 · Institut Claudius Regaud, Other · Terminated
Key facts
| NCT number | NCT00210028 |
|---|---|
| Title | Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer |
| Official title | Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor |
| Lead sponsor | Institut Claudius Regaud, Other |
| Collaborators | Janssen-Cilag Ltd. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Tamoxifen, Zarnestra |
| Enrollment | 40 |
| Start date | Aug 1, 2003 |
| Completion | Aug 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 14, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: